Squarepoint Ops LLC Takes $683,000 Position in Enfusion, Inc. (NYSE:ENFN)

Squarepoint Ops LLC purchased a new position in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 80,126 shares of the company's stock, valued at approximately $683,000. Squarepoint Ops LLC owned about 0.06% of Enfusion at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Scalar Gauge Management LLC grew its holdings in Enfusion by 21.8% during the 2nd quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company's stock valued at $5,227,000 after purchasing an additional 110,000 shares in the last quarter. 272 Capital LP grew its position in shares of Enfusion by 1.5% during the second quarter. 272 Capital LP now owns 139,180 shares of the company's stock worth $1,186,000 after acquiring an additional 2,000 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Enfusion by 167.6% in the second quarter. Renaissance Technologies LLC now owns 97,100 shares of the company's stock worth $827,000 after purchasing an additional 60,811 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Enfusion by 57.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company's stock valued at $4,466,000 after purchasing an additional 191,436 shares in the last quarter. Finally, American Century Companies Inc. raised its position in Enfusion by 17.1% in the second quarter. American Century Companies Inc. now owns 35,897 shares of the company's stock worth $306,000 after acquiring an additional 5,253 shares in the last quarter. 81.05% of the stock is currently owned by institutional investors and hedge funds.

Enfusion Stock Performance

Shares of NYSE ENFN traded up $0.09 during mid-day trading on Wednesday, reaching $8.98. The company had a trading volume of 357,936 shares, compared to its average volume of 376,712. The company has a market capitalization of $1.15 billion, a price-to-earnings ratio of 301.00, a PEG ratio of 2.63 and a beta of 0.92. Enfusion, Inc. has a 12-month low of $7.52 and a 12-month high of $10.45. The stock has a fifty day moving average of $8.51 and a two-hundred day moving average of $8.89.

Enfusion (NYSE:ENFN - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.01). Enfusion had a return on equity of 6.17% and a net margin of 1.98%. The firm had revenue of $49.46 million for the quarter, compared to the consensus estimate of $50.27 million. Sell-side analysts forecast that Enfusion, Inc. will post 0.07 earnings per share for the current fiscal year.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.